Stable 5,6-Epoxyeicosatrienoic Acid Analog Relaxes Coronary Arteries Through Potassium Channel Activation
- 1 April 2005
- journal article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 45 (4), 681-686
- https://doi.org/10.1161/01.hyp.0000153790.12735.f9
Abstract
5,6-Epoxyeicosatrienoic acid (5,6-EET) is a cytochrome P450 epoxygenase metabolite of arachidonic acid that causes vasorelaxation. However, investigations of its role in biological systems have been limited by its chemical instability. We developed a stable agonist of 5,6-EET, 5-(pentadeca-3(Z),6(Z),9(Z)-trienyloxy)pentanoic acid (PTPA), in which the 5,6-epoxide was replaced with a 5-ether. PTPA obviates chemical and enzymatic hydrolysis. In bovine coronary artery rings precontracted with U46619, PTPA (1 nmol/L to 10 μmol/L) induced concentration-dependent relaxations, with maximal relaxation of 86±5% and EC 50 of 1 μmol/L. The relaxations were inhibited by the cyclooxygenase inhibitor indomethacin (10 μmol/L; max relaxation 43±9%); the ATP-sensitive K + channel inhibitor glybenclamide (10 μmol/L; max relaxation 49±6%); and the large conductance calcium-activated K + channel inhibitor iberiotoxin (100 nmol/L; max relaxation 38±6%) and abolished by the combination of iberiotoxin with indomethacin or glybenclamide or increasing extracellular K + to 20 mmol/L. Whole-cell outward K + current was increased nearly 6-fold by PTPA (10 μmol/L), which was also blocked by iberiotoxin. Additionally, we synthesized 5-(pentadeca-6(Z),9(Z)-dienyloxy)pentanoic acid and 5-(pentadeca-3(Z),9(Z)-dienyloxy)pentanoic acid (PDPA), PTPA analogs that lack the 8,9 or 11,12 double bonds of arachidonic acid and therefore are not substrates for cyclooxygenase. The PDPAs caused concentration-dependent relaxations (max relaxations 46±13% and 52±7%, respectively; EC 50 1μmol/L), which were not altered by glybenclamide but blocked by iberiotoxin. These studies suggested that PTPA induces relaxation through 2 mechanisms: (1) cyclooxygenase-dependent metabolism to 5-ether–containing prostaglandins that activate ATP-sensitive K + channels and (2) activation of smooth muscle large conductance calcium-activated K + channels. PDPAs only activate large conductance calcium-activated K + channels.Keywords
This publication has 17 references indexed in Scilit:
- 14,15-EET analogs: characterization of structural requirements for agonist and antagonist activity in bovine coronary arteriesPharmacological Research, 2004
- 14,15-Epoxyeicosa-5( Z )-enoic AcidCirculation Research, 2002
- Liquid Chromatographic–Electrospray Ionization–Mass Spectrometric Analysis of Cytochrome P450 Metabolites of Arachidonic AcidAnalytical Biochemistry, 2001
- Epoxygenase Metabolites: Epithelial and Vascular ActionsMolecular Biotechnology, 2000
- Cytochrome P450-dependent effects of bradykinin in the rat heartBritish Journal of Pharmacology, 1995
- Metabolism of Epoxyeicosatrienoic Acids by Cytosolic Epoxide Hydrolase: Substrate Structural Determinants of Asymmetric CatalysisArchives of Biochemistry and Biophysics, 1995
- Cytochrome P-450 Metabolism of Arachidonic AcidAnnual Review of Pharmacology and Toxicology, 1991
- Epoxygenase Products of Arachidonic Acid Are Endogenous Constituents of the Hypothalamus Involved in D2Receptor-Mediated, Dopamine-Induced Release of SomatostatinEndocrinology, 1990
- Prostaglandin Biosynthesis and its Compartmentation in Vascular Smooth Muscle and Endothelial CellsAnnual Review of Physiology, 1986
- Metabolism of 5(6)-expoxyeicosatrienoic acid by ram seminal vesiclesBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1984